Landmark decision: FDA Approves 23andMe Genetic Test

23andMe

23andMe CEO, Anne Wojcicki, just emailed 23andMe customers (me included) with the big news that the FDA has approved the company to offer Bloom syndrome carrier status reporting. As Wojcicki points out, this is the first time ever that the FDA has granted authorization of a direct-to-consumer genetic test. This is a huge deal. Why …

Landmark decision: FDA Approves 23andMe Genetic Test Read More »